Diligence memo · auto-generated · as of July 2, 2026

Sunset At El Paso Llc

Sunset At El Paso Llc looks over-valued against its niche peers and is active on financing cadence.

SourceRaising on rhythm with a 53.8× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Sunset At El Paso Llc operates in Other, based in COLORADO SPRINGS.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Sunset At El Paso Llc has raised $98M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $96M on 2025-09-18.

Most recent recorded round closed around 2025-09-18.

Valuation (modeled)modeled

Provath models Sunset At El Paso Llc at approximately $585M (range $372M–$753M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.16× the median modeled value of Series C Other companies in 2025–2027 (76 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 3 months.

Last raise 9 mo ago; this sector typically re-raises about every 11 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 53.8× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 96% of Other peers (25015 compared).

Modeled value ranks above 95% of those peers.

Closest niche peers: Premium Packaged Products LLC, Hoagie Investor Holdings, LLC, Orion Street Capital LLC, Mozella Capital Inc., SE-Las Colinas.

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Modeled above niche peers — valuation risk on entry.

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.